Amgen Initiates Recall of Heart Medication Due to Contamination Concerns

Pharmaceutical company Amgen is voluntarily recalling almost one million bottles of its heart drug, Corlanor, following the discovery of a foreign substance. The U.S. Food and Drug Administration has classified this as a Class II recall, indicating a low probability of serious health consequences, though temporary effects are possible. The recall also extends to some Sensipar bottles due to manufacturing issues.